168 related articles for article (PubMed ID: 31231988)
1. RECQL5 plays an essential role in maintaining genome stability and viability of triple-negative breast cancer cells.
Peng J; Tang L; Cai M; Chen H; Wong J; Zhang P
Cancer Med; 2019 Aug; 8(10):4743-4752. PubMed ID: 31231988
[TBL] [Abstract][Full Text] [Related]
2. The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells.
Wang J; Dong Y; Ma H; Wu L; Zhen X; Tang L; Jin J; Han S; Zhang P; Peng J
J Biol Chem; 2022 Jan; 298(1):101443. PubMed ID: 34822842
[TBL] [Abstract][Full Text] [Related]
3. RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability.
Chen E; Ahn JS; Sykes DB; Breyfogle LJ; Godfrey AL; Nangalia J; Ko A; DeAngelo DJ; Green AR; Mullally A
Cell Rep; 2015 Dec; 13(11):2345-2352. PubMed ID: 26686625
[TBL] [Abstract][Full Text] [Related]
4. Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.
Popuri V; Tadokoro T; Croteau DL; Bohr VA
Crit Rev Biochem Mol Biol; 2013; 48(3):289-99. PubMed ID: 23627586
[TBL] [Abstract][Full Text] [Related]
5. A Blm-Recql5 partnership in replication stress response.
Lu X; Lou H; Luo G
J Mol Cell Biol; 2011 Feb; 3(1):31-8. PubMed ID: 21278449
[TBL] [Abstract][Full Text] [Related]
6. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.
Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G
Genes Dev; 2007 Dec; 21(23):3073-84. PubMed ID: 18003859
[TBL] [Abstract][Full Text] [Related]
7. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
8. RecQ family helicases in genome stability: lessons from gene disruption studies in DT40 cells.
Seki M; Otsuki M; Ishii Y; Tada S; Enomoto T
Cell Cycle; 2008 Aug; 7(16):2472-8. PubMed ID: 18719387
[TBL] [Abstract][Full Text] [Related]
9. Catalytic strand separation by RECQ1 is required for RPA-mediated response to replication stress.
Banerjee T; Sommers JA; Huang J; Seidman MM; Brosh RM
Curr Biol; 2015 Nov; 25(21):2830-2838. PubMed ID: 26455304
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer.
Boerner JL; Nechiporchik N; Mueller KL; Polin L; Heilbrun L; Boerner SA; Zoratti GL; Stark K; LoRusso PM; Burger A
PLoS One; 2015; 10(3):e0119614. PubMed ID: 25774912
[TBL] [Abstract][Full Text] [Related]
11. Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer.
Jabbour-Leung NA; Chen X; Bui T; Jiang Y; Yang D; Vijayaraghavan S; McArthur MJ; Hunt KK; Keyomarsi K
Mol Cancer Ther; 2016 Apr; 15(4):593-607. PubMed ID: 26826118
[TBL] [Abstract][Full Text] [Related]
12. Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
Patterson K; Arya L; Bottomley S; Morgan S; Cox A; Catto J; Bryant HE
Oncotarget; 2016 Nov; 7(46):76140-76150. PubMed ID: 27764811
[TBL] [Abstract][Full Text] [Related]
13. TIPIN depletion leads to apoptosis in breast cancer cells.
Baldeyron C; Brisson A; Tesson B; Némati F; Koundrioukoff S; Saliba E; De Koning L; Martel E; Ye M; Rigaill G; Meseure D; Nicolas A; Gentien D; Decaudin D; Debatisse M; Depil S; Cruzalegui F; Pierré A; Roman-Roman S; Tucker GC; Dubois T
Mol Oncol; 2015 Oct; 9(8):1580-98. PubMed ID: 26004086
[TBL] [Abstract][Full Text] [Related]
14. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.
Wen Y; Dai G; Wang L; Fu K; Zuo S
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842344
[TBL] [Abstract][Full Text] [Related]
15. RECQL5 has unique strand annealing properties relative to the other human RecQ helicase proteins.
Khadka P; Croteau DL; Bohr VA
DNA Repair (Amst); 2016 Jan; 37():53-66. PubMed ID: 26717024
[TBL] [Abstract][Full Text] [Related]
16. RecQL5 promotes genome stabilization through two parallel mechanisms--interacting with RNA polymerase II and acting as a helicase.
Islam MN; Fox D; Guo R; Enomoto T; Wang W
Mol Cell Biol; 2010 May; 30(10):2460-72. PubMed ID: 20231364
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
18. The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine.
Parvathaneni S; Sharma S
J Biol Chem; 2019 Oct; 294(42):15330-15345. PubMed ID: 31444271
[TBL] [Abstract][Full Text] [Related]
19. Human RECQL5 participates in the removal of endogenous DNA damage.
Tadokoro T; Ramamoorthy M; Popuri V; May A; Tian J; Sykora P; Rybanska I; Wilson DM; Croteau DL; Bohr VA
Mol Biol Cell; 2012 Nov; 23(21):4273-85. PubMed ID: 22973052
[TBL] [Abstract][Full Text] [Related]
20. mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.
Mo W; Liu Q; Lin CC; Dai H; Peng Y; Liang Y; Peng G; Meric-Bernstam F; Mills GB; Li K; Lin SY
Clin Cancer Res; 2016 Apr; 22(7):1699-712. PubMed ID: 26546619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
